IMMUTEP ADR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.98 USD | +3.83% |
|
+4.93% | +24.17% |
| 17/05 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
| 15/05 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 54.63B | - | |||||
| 39.92B | ||||||
| 26.86B | ||||||
| 26.22B | ||||||
| 18.78B | - |
